Back to Search
Start Over
Elevated plasma phage load as a marker for intestinal permeability in leukemic patients.
- Source :
-
Medical microbiology and immunology [Med Microbiol Immunol] 2020 Dec; Vol. 209 (6), pp. 693-703. Date of Electronic Publication: 2020 Sep 29. - Publication Year :
- 2020
-
Abstract
- Microbial translocation (MT) and altered gut microbiota have been described in acute leukemic patients and contribute to immune activation and inflammation. However, phage translocation has not been investigated in leukemia patients yet. We recruited 44 leukemic patients and 52 healthy adults and quantified the levels of 3 phages in peripheral blood, which were the most positive phages screened from fecal samples. The content of 16S rRNA in plasma was detected by qPCR to assess the intestinal mucosa of these patients. Spearman's rank correlation was used to analyze the relationship between phage load and the relevant clinical data. We found the most prevalent phages in fecal samples were λ phage, Wphi phage, and P22 phage, and λ phage had the highest detection rate in plasma (68%). Phage content was affected by chemotherapy and course of disease and correlated with the levels of CRP (r = 0.43, p = 0.003), sCD14 (r = 0.37, p = 0.014), and sCD163 (r = 0.44, p = 0.003). Our data indicate that plasma phage load is a promising marker for gut barrier damage and that gut phage translocation correlates with monocyte/macrophage activation and systemic inflammatory response in leukemic patients.
- Subjects :
- Adult
Aged
Antigens, CD blood
Antigens, Differentiation, Myelomonocytic blood
Antineoplastic Agents adverse effects
Antineoplastic Agents pharmacology
C-Reactive Protein analysis
Female
Humans
Intestinal Mucosa microbiology
Leukemia, Myeloid, Acute drug therapy
Leukemia, Myeloid, Acute microbiology
Leukemia, Myeloid, Acute virology
Lipopolysaccharide Receptors blood
Macrophage Activation
Male
Middle Aged
Permeability
Precursor Cell Lymphoblastic Leukemia-Lymphoma blood
Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma microbiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma virology
Receptors, Cell Surface blood
Viremia etiology
CD163 Antigen
Bacterial Translocation
Bacteriophages isolation & purification
Gastrointestinal Microbiome
Intestinal Mucosa drug effects
Leukemia, Myeloid, Acute blood
RNA, Bacterial blood
RNA, Ribosomal, 16S blood
Viremia diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1432-1831
- Volume :
- 209
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Medical microbiology and immunology
- Publication Type :
- Academic Journal
- Accession number :
- 32995957
- Full Text :
- https://doi.org/10.1007/s00430-020-00694-y